CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System

NCT ID: NCT01896219

Last Updated: 2018-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

464 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Estimate the medical service of a system of navigation (IMACTIS-CT®)in terms of SAFETY, EFFICIENCY and PERFORMANCE, in comparison with the reference method during gestures of interventional radiology under scan in the thoraco-abdominal level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drainage Biopsy Punction Ablation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gesture performed under control tomodensitometric (CT)

Conventional

Group Type ACTIVE_COMPARATOR

CT

Intervention Type DEVICE

Reference method for gestures (carried out under CT) guidance

Gesture performed under Navigation-assisted procedure (NAV)

Use of the IMACTIS-CT® Navigation System

Group Type EXPERIMENTAL

Navigation station (IMACTIS-CT®)

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Navigation station (IMACTIS-CT®)

Intervention Type DEVICE

CT

Reference method for gestures (carried out under CT) guidance

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Navigation station for gestures (carried out under CT) guidance

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* More or equal the 18 years old
* Patient for whom an indication of diagnostic or therapeutic percutaneous interventional gesture in the thoraco-abdominal level under CT guidance is prescribed
* Patient affiliated to social security or similarly regime
* Patient signed consent for participation in the study.

Exclusion Criteria

* Patient with a medical device using a magnetic field (eg, patient with a pacemaker)
* Patient who presents ferromagnetic foreign bodies intracorporeal close to the working zone of Radiologist, and that can interact with the medical device
* Pregnant women and lactating mothers
* Ward of court or under guardianship
* Person deprived of freedom by judicial or administrative decision
* Person under legal protection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ivan Bricault, Pr

Role: PRINCIPAL_INVESTIGATOR

Radiology Departement - University Hospital of Grenoble

Eric Delabrousse, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Besançon

Bruno Lapuyade, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Bordeaux

Pascal Lacombe, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Garches

Laurent Lemaitre, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Lille

Valérie Laurent, Pr

Role: PRINCIPAL_INVESTIGATOR

CHU NANCY

Jean-Yves Gauvrit, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Rennes

Olivier Favelle, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Tours

Eric De Kerviler, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Saint-Louis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital

Besançon, Doubs, France

Site Status

University Hospital

Bordeaux, Gironde, France

Site Status

Ambroise Paré University Hospital

Boulogne-Billancourt, Hauts-de-Seine, France

Site Status

University Hospital

Rennes, Ille-et-Vilaine, France

Site Status

University Hospital

Tours, Indre-et-Loire, France

Site Status

University Hospital

Grenoble, Isère, France

Site Status

University Hospital

Nancy, Meuse, France

Site Status

University Hospital

Lille, Nord, France

Site Status

University Hospital of Saint-Louis

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Rouchy RC, Moreau-Gaudry A, Chipon E, Aubry S, Pazart L, Lapuyade B, Durand M, Hajjam M, Pottier S, Renard B, Logier R, Orry X, Cherifi A, Quehen E, Kervio G, Favelle O, Patat F, De Kerviler E, Hughes C, Medici M, Ghelfi J, Mounier A, Bricault I. Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised controlled trial. Trials. 2017 Jul 6;18(1):306. doi: 10.1186/s13063-017-2049-6.

Reference Type DERIVED
PMID: 28683837 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A00539-36

Identifier Type: OTHER

Identifier Source: secondary_id

DCIC 12 29

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.